/ weekly 1.0 /compounds weekly 0.9 /research-areas weekly 0.8 /database weekly 0.8 /calculator 0.6 /coa 0.6 /assistant 0.7 /compliance 0.4 /compounds/bpc-157 0.8 /compounds/tb-500 0.8 /compounds/cjc-1295-with-dac 0.8 /compounds/cjc-1295-without-dac 0.8 /compounds/ipamorelin 0.8 /compounds/ghrp-2 0.8 /compounds/ghrp-6 0.8 /compounds/igf-1-lr3 0.8 /compounds/ghk-cu 0.8 /compounds/melanotan-ii 0.8 /compounds/mots-c 0.8 /compounds/selank 0.8 /compounds/semax 0.8 /compounds/semaglutide 0.8 /compounds/retatrutide 0.8 /compounds/tesamorelin 0.8 /compounds/sermorelin 0.8 /compounds/hgh-somatropin 0.8 /compounds/oxytocin 0.8 /compounds/nad-plus 0.8 /research-areas/endocrine-research 0.6 /research-areas/metabolic-research 0.6 /research-areas/neuroscience-research 0.6 /research-areas/tissue-recovery-research 0.6 /research-areas/dermatological-research 0.6 /research-areas/longevity-research 0.6 /research-areas/regenerative-biology 0.6 /research-areas/analytical-chemistry 0.6 /pathways/gh-igf1-axis 0.5 /pathways/glp1-signalling 0.5 /pathways/ghrh-signalling 0.5 /pathways/melanocortin-signalling 0.5 /pathways/mitochondrial-signalling 0.5 /studies/stable-gastric-pentadecapeptide-bpc-157-and-wound-healing 0.5 /studies/bpc-157-and-standard-angiogenic-growth-factors 0.5 /studies/bpc-157-multifunctionality-literature-patent-review 0.5 /studies/injectable-peptides-sports-medicine-narrative-review 0.5 /studies/smart-healing-wound-repair-regenerative-medicine 0.5 /studies/thymosin-beta4-accelerates-wound-healing 0.5 /studies/thymosin-beta4-promotes-angiogenesis-wound-healing-and-hair-follicle-development 0.5 /studies/progress-on-the-function-and-application-of-thymosin-beta4 0.5 /studies/injectable-peptides-sports-medicine-narrative-review 0.5 /studies/smart-healing-wound-repair-regenerative-medicine 0.5 /studies/prolonged-stimulation-of-gh-and-igf-i-by-cjc-1295 0.5 /studies/pulsatile-secretion-of-gh-persists-following-cjc-1295 0.5 /studies/human-growth-hormone-releasing-factor-hgrf-1-29-analogs-and-cjc-1295 0.5 /studies/ghrh-1-29-nh2-and-analogs-in-normal-men 0.5 /studies/ipamorelin-the-first-selective-growth-hormone-secretagogue 0.5 /studies/safety-and-efficacy-of-growth-hormone-secretagogues 0.5 /studies/growth-hormone-releasing-peptide-2-like-ghrelin-increases-food-intake-in-healthy-men 0.5 /studies/effects-of-ghrp-2-and-hexarelin-on-gh-prl-acth-and-cortisol 0.5 /studies/effects-of-ghrelin-ghrp-6-and-ghrh-on-gh-acth-and-cortisol 0.5 /studies/effects-of-growth-hormone-secretagogues-on-prolactin-and-acth 0.5 /studies/ghrp-6-postinfarct-ventricular-remodeling 0.5 /studies/ghrp-6-unnatural-peptide-begets-ghrelin 0.5 /studies/ghrp-6-secretagogue-ghrh-somatostatin-interactions 0.5 /studies/implications-of-igf-1-in-skeletal-muscle-and-disease 0.5 /studies/therapeutic-potential-of-igf-i-in-skeletal-muscle-repair 0.5 /studies/effects-of-insulin-and-igfs-on-protein-and-energy-metabolism-in-tumour-bearing-rats 0.5 /studies/regenerative-and-protective-actions-of-the-ghk-cu-peptide 0.5 /studies/ghk-peptide-as-a-natural-modulator-of-multiple-cellular-pathways 0.5 /studies/human-tripeptide-ghk-and-tissue-remodeling 0.5 /studies/copper-tripeptide-growth-factor-expression 0.5 /studies/nonprescription-topical-treatments-skin-rejuvenation 0.5 /studies/therapeutic-peptides-aesthetic-metabolic-endocrine-conditions 0.5 /studies/smart-healing-wound-repair-regenerative-medicine 0.5 /studies/melanocortin-peptide-therapeutics-historical-milestones 0.5 /studies/benefits-and-risks-of-chronic-melanocortin-1-receptor-activation 0.5 /studies/mt-ii-and-central-melanocortin-receptors 0.5 /studies/bremelanotide-salvage-sildenafil-failures 0.5 /studies/pt-141-sildenafil-coadministration-erectile 0.5 /studies/melanotan-ii-atypical-melanocytic-naevi 0.5 /studies/afamelanotide-erythropoietic-protoporphyria-review 0.5 /studies/semax-melanotan-ii-antidepressant-antistress-acth 0.5 /studies/mots-c-a-novel-mitochondrial-derived-peptide-regulating-metabolism 0.5 /studies/mitochondria-derived-peptide-mots-c-effects-and-mechanisms 0.5 /studies/mots-c-a-promising-mitochondrial-derived-peptide-for-metabolic-disease 0.5 /studies/selank-administration-affects-expression-of-genes-involved-in-neurotransmission 0.5 /studies/functional-connectomic-approach-to-studying-selank-and-semax-effects 0.5 /studies/selank-anxiolytic-generalized-anxiety-disorder 0.5 /studies/selank-intranasal-bdnf-hippocampus 0.5 /studies/selank-ethanol-memory-bdnf-protection 0.5 /studies/semax-selank-behavior-parkinson-6ohda-rats 0.5 /studies/semax-selank-thermal-burn-wounds-structural 0.5 /studies/neuropeptides-bioactive-neurodegeneration-oxidative-stress 0.5 /studies/peptide-semax-affects-expression-of-genes-related-to-vascular-function-in-focal-ischemia 0.5 /studies/functional-connectomic-approach-to-studying-selank-and-semax-effects-semax 0.5 /studies/semax-ischemic-stroke-clinical-efficacy 0.5 /studies/semax-bdnf-trkb-hippocampus 0.5 /studies/semax-neurotrophin-transcription-ischemia 0.5 /studies/semax-potential-alzheimers-disease-correction 0.5 /studies/semax-selank-behavior-parkinson-6ohda-rats 0.5 /studies/semax-selank-thermal-burn-wounds-structural 0.5 /studies/semax-universal-drug-therapy-research 0.5 /studies/semax-melanotan-ii-antidepressant-antistress-acth 0.5 /studies/neuropeptides-bioactive-neurodegeneration-oxidative-stress 0.5 /studies/once-weekly-semaglutide-in-adults-with-overweight-or-obesity 0.5 /studies/semaglutide-statpearls-ncbi-bookshelf 0.5 /studies/two-year-effects-of-semaglutide-in-adults-with-overweight-or-obesity 0.5 /studies/semaglutide-promising-antiobesity-drug-review 0.5 /studies/semaglutide-clinical-insight-chronic-weight-management 0.5 /studies/cagrilintide-semaglutide-overweight-obesity-nejm 0.5 /studies/cardiovascular-effects-semaglutide-tirzepatide 0.5 /studies/therapeutic-peptides-aesthetic-metabolic-endocrine-conditions 0.5 /studies/triple-hormone-receptor-agonist-retatrutide-for-obesity 0.5 /studies/commentary-on-the-novel-triagonist-retatrutide-for-obesity 0.5 /studies/retatrutide-triple-agonist-paradigm-shift 0.5 /studies/tesamorelin-a-growth-hormone-releasing-factor-analogue-for-hiv-associated-lipodystrophy 0.5 /studies/efficacy-and-safety-of-tesamorelin-in-people-with-hiv-and-abdominal-fat-accumulation 0.5 /studies/sermorelin-review-of-use-in-diagnosis-and-treatment-of-gh-deficiency 0.5 /studies/sermorelin-management-of-adult-onset-growth-hormone-insufficiency 0.5 /studies/clinical-indications-for-growth-hormone-therapy 0.5 /studies/somatropin-for-short-stature 0.5 /studies/adult-gh-deficiency-endocrine-society-guideline 0.5 /studies/rudman-growth-hormone-men-over-60 0.5 /studies/somatopause-growth-hormone-replacement 0.5 /studies/oxytocin-a-social-peptide-deconstructing-the-evidence 0.5 /studies/oxytocin-as-treatment-for-social-cognition-not-there-yet 0.5 /studies/beyond-labor-the-role-of-natural-and-synthetic-oxytocin 0.5 /studies/nad-metabolism-and-its-roles-in-cellular-processes-during-ageing 0.5 /studies/dietary-supplementation-with-nad-boosting-compounds-in-humans 0.5 /studies/role-of-nad-in-regenerative-medicine 0.5 /studies/nmn-muscle-insulin-sensitivity-prediabetic 0.5 /studies/nad-sirtuins-aging-disease-review 0.5 /studies/nicotinamide-riboside-vascular-health 0.5